Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INHALEd Unfractionated HEParin for the Treatment of Hospitalized Patients With COVID-19 Pneumonia

NCT04723563 is registered in ClinicalTrials.gov with Frederick Health as lead sponsor.

NCT NCT04723563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04723563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INHALEd Unfractionated HEParin for the Treatment of Hospitalized Patients With COVID-19 Pneumonia
Lead sponsor
Frederick Health
Phase
Phase 4
Overall status
Completed
Start date
February 22, 2021
Completion date
August 23, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, pneumonia, viral